Drugs@FDA document
METHYLIN Letter · NDA 021419 SUPPL-23
Drugs@FDA document · SPECGX LLC · Oct 16, 2023
Key facts
| Drug name | METHYLIN |
|---|---|
| Document type | Letter |
| Application | NDA021419 |
| Submission | SUPPL-23 |
| Company | SPECGX LLC |
| Document date | Oct 16, 2023 |
| FDA document | web.archive.org |
At a glance
- Labeling-Medication Guide, Labeling-Package Insert Document categories
- 10–99 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: